ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

“One Time Offer” On Comprehensiveness Approved By NCAB

September 22, 1989

NCI Human Tissue Network Resources Available For Research

January 24, 1997

Committee Approves NDA For Tamoxifen

January 21, 1977

Also in this 8-page issue: NCI closes its Tobacco Intervention Research Clinic, blaming flat budget, slow accrual.

October 15, 2004

Institute Of Medicine: External Experts Should Vet Large Projects, Report Says.

June 20, 2003

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

June 18, 1993